1 not yet recruiting, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Mycobacterium Abscessus Pulmonary Disease: new trials by email Literature Review of Mycobacterium Abscessus Pulmonary Disease trials Research Report on Mycobacterium Abscessus Pulmonary Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | Phase 2 | Not yet recruiting | The University of Queensland | 300 | 2027-04-01 | 2026-03-20 |
| TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease Chinese herbs-I, Chinese herbs-I placebo, Chinese herbs-II - Mycobacterium Abscessus Pulmonary Disease | Phase 2 | Recruiting | Shanghai University of Traditional Chinese Medicine | 352 | 2025-09-08 | 2025-12-22 |
Infections (1) · Mycobacterium Infections, Nontuberculous (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Mycobacterium Infections (1)
Amikacin (1) · Amoxicillin (1) · Cefoxitin (1) · Ceftriaxone (1) · Cilastatin, Imipenem Drug Combination (1) · Clarithromycin (1) · Clofazimine (1) · Doxycycline (1) · Ethambutol (1) · Inhalation (1) · Injections (1) · Linezolid (1) · Moxifloxacin (1) · Rifabutin (1) · Sulbactam (1)
Shanghai University of Traditional Chinese Medicine (1) · The University of Queensland (1)
China (1)
Zhenhui Lu (1)